Stock listing

Incyte Corporation

Selected listing: I1NC34 · BMFBOVESPA · BRL · BR

Incyte Corporation (B3:I1NC34), Health Technology. Latest release Sep 22, 2026: Incyte Data at the European Academy of Dermatology and Venereology (EADV)…

I1NC34:BMFBOVESPABRLBRUpdated October 2, 2026

Ticker: B3:I1NC34
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: B3
Currency: BRL

Latest news from Incyte Corporation

Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and Autoimmunity Portfolio

September 22, 2026

Incyte Announces Funding of MINJUVI® (tafasitamab) for patients with Relapsed or Refractory Follicular Lymphoma through Ontario's FAST Program

September 10, 2026

Incyte - Opzelura Cream Becomes First Steroid-Free Topical JAK Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis

July 30, 2026

Opzelura® (ruxolitinib) Cream Becomes First Steroid-Free Topical JAK Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis

July 29, 2026

Incyte Reports Second Quarter 2026 Financial Results and Provides Business Updates

July 28, 2026

All Incyte Corporation news →

Events

Replays

Incyte Corporation (INCY) Q2 2026 Earnings Call
Tue, Jul 28, 2026 · 08:00 AM ET
Watch
Incyte Corporation (INCY) Q1 2026 Earnings Call
Tue, Apr 28, 2026 · 08:00 AM ET
Watch
Incyte Corporation (INCY) Q4 2025 Earnings Call
Tue, Feb 10, 2026 · 08:00 AM ET
Watch

Research Incyte Corporation

Incyte Corporation company profile

View the public company page for Incyte Corporation on 6ix.

Incyte Corporation news

Read company news and market updates connected to Incyte Corporation.

Incyte Corporation investor events

Find investor webinars, events, and replay context for Incyte Corporation.